STAAR Surgical Profit Margin 2010-2024 | STAA

Current and historical gross margin, operating margin and net profit margin for STAAR Surgical (STAA) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. STAAR Surgical net profit margin as of September 30, 2024 is 6.38%.
STAAR Surgical Annual Profit Margins
STAAR Surgical Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.231B $0.322B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $73.526B 20.06
Becton Dickinson (BDX) United States $64.714B 17.01
Cardinal Health (CAH) United States $28.315B 15.35
West Pharmaceutical Services (WST) United States $23.683B 48.37
Labcorp (LH) United States $18.984B 15.74
Cooper (COO) United States $18.348B 24.85
Align Technology (ALGN) United States $15.944B 30.51
Henry Schein (HSIC) United States $8.597B 16.38
Merit Medical Systems (MMSI) United States $5.611B 28.65
DENTSPLY SIRONA (XRAY) United States $3.671B 9.98
Patterson (PDCO) United States $2.730B 14.58
CONMED (CNMD) United States $2.162B 18.04
Lifevantage (LFVN) United States $0.222B 29.55
Pro-Dex (PDEX) United States $0.151B 30.10